Clorox (NYSE:CLX – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 6.650-6.900 for the period, compared to the consensus earnings per share estimate of 6.650. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Clorox also updated its FY25 guidance to $6.65-$6.90 EPS.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the company. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and raised their target price for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. BNP Paribas raised Clorox to a “strong sell” rating in a report on Friday, September 6th. DA Davidson reaffirmed a “neutral” rating and set a $153.00 target price on shares of Clorox in a report on Friday, September 6th. Wells Fargo & Company dropped their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. Finally, Barclays raised their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday. Six research analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $150.29.
Check Out Our Latest Stock Report on Clorox
Clorox Trading Up 2.9 %
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 292.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the business posted $0.49 earnings per share. The firm’s revenue was up 27.0% compared to the same quarter last year. On average, equities research analysts expect that Clorox will post 6.64 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 2.99%. Clorox’s dividend payout ratio is currently 170.04%.
Insider Buying and Selling at Clorox
In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.57% of the company’s stock.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Using the MarketBeat Stock Split Calculator
- Battle of the Retailers: Who Comes Out on Top?
- How to Choose Top Rated Stocks
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.